At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Type Sorted Ascending Shares Traded Price Range
Jun 2, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.20
May 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.81
Sep 2, 2008 dentzer james e Officer Disposition (Non Open Market) 220 13.86
Oct 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 15.10
Feb 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.24
Jan 2, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.34
Mar 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 9.85
Oct 2, 2007 dentzer james e Officer Disposition (Non Open Market) 2,500 17.35
Nov 1, 2007 dentzer james e Officer Disposition (Non Open Market) 220 16.17
Dec 3, 2007 dentzer james e Officer Disposition (Non Open Market) 220 15.30
Jun 5, 2007 barkas alexander e Director Option Execute 15,119 6.38
Jun 5, 2007 barris peter j Beneficial Owner (10% or more) Option Execute 15,077 6.38
Dec 13, 2007 crowley john f Officer Option Execute 10,000 0.64
Dec 14, 2007 crowley john f Officer Option Execute 5,000 0.64
Jun 21, 2007 crowley john f Officer Option Execute 33,736 0.64
Feb 29, 2008 crowley john f Officer Option Execute 10,000 0.64
Jan 2, 2008 crowley john f Officer Option Execute 20,000 0.64
Oct 28, 2008 crowley john f Officer Option Execute 40,000 0.64 - 5.33
Mar 11, 2009 crowley john f Officer Option Execute 1,000 5.33
Mar 30, 2012 crowley john f Officer Option Execute 49,931 0.64
Showing 321-340 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy